RAB5A and amyotrophic lateral sclerosis: Also, constitutively active Rab5 ameliorates neurodegenerative processes in both gain- and loss-of-function C9orf72 mouse models [128], thus revealing Rab activity and lysosomal function as potential therapeutic targets for C9orf72-linked ALS.